PBH PRESTIGE CONSMR HEALTHCARE I revenue, earnings and financials

For the quarter ended June 30, 2026, PRESTIGE CONSMR HEALTHCARE I reported revenue of $266M (up 6.5% from a year earlier), net income of $29.2M and diluted EPS of $0.61; over the last four quarters revenue was $1.10B and net income $172M; for the fiscal year ended March 2026 revenue was $1.09B, down 4.3% on the year before.

PBH annual revenue and earnings

• Fiscal year ended Mar 2026: revenue $1.09B, gross profit $596M, operating income $309M, net income $190M (margin 17.5%), EPS $3.91
• Fiscal year ended Mar 2025: revenue $1.14B, gross profit $634M, operating income $337M, net income $215M (margin 18.9%), EPS $4.29
• Fiscal year ended Mar 2024: revenue $1.13B, gross profit $624M, operating income $342M, net income $209M (margin 18.6%), EPS $4.17
• Fiscal year ended Mar 2023: revenue $1.13B, gross profit $625M, operating income −$22.4M, net income −$82.3M (margin -7.3%), EPS −$1.65
• Fiscal year ended Mar 2022: revenue $1.09B, gross profit $621M, operating income $330M, net income $205M (margin 18.9%), EPS $4.04

PBH quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $266M (up 6.5% year over year), net income $29.2M, EPS $0.61
• Quarter ended Mar 31, 2026 (from the annual report): revenue $282M (down 5.0% year over year), net income $53.9M, EPS $1.13
• Quarter ended Dec 31, 2025: revenue $283M (down 2.4% year over year), net income $46.7M, EPS $0.97
• Quarter ended Sep 30, 2025: revenue $274M (down 3.4% year over year), net income $42.2M, EPS $0.86
• Quarter ended Jun 30, 2025: revenue $250M (down 6.6% year over year), net income $47.5M, EPS $0.95
• Quarter ended Mar 31, 2025 (from the annual report): revenue $297M (up 7.0% year over year), net income $50.1M, EPS $1.00
• Quarter ended Dec 31, 2024: revenue $290M (up 2.7% year over year), net income $61.0M, EPS $1.22
• Quarter ended Sep 30, 2024: revenue $284M (down 0.9% year over year), net income $54.4M, EPS $1.09
• Quarter ended Jun 30, 2024: revenue $267M (down 4.4% year over year), net income $49.1M, EPS $0.98
• Quarter ended Mar 31, 2024 (from the annual report): revenue $277M (down 3.1% year over year), net income $49.4M, EPS $0.98
• Quarter ended Dec 31, 2023: revenue $283M (up 2.6% year over year), net income $53.0M, EPS $1.06
• Quarter ended Sep 30, 2023: revenue $286M (down 1.0% year over year), net income $53.6M, EPS $1.07
• Quarter ended Jun 30, 2023: revenue $279M (up 0.8% year over year), net income $53.3M, EPS $1.06
• Quarter ended Mar 31, 2023 (from the annual report): revenue $286M (up 7.1% year over year), net income −$241M, EPS −$4.80
• Quarter ended Dec 31, 2022: revenue $276M (up 0.4% year over year), net income $52.0M, EPS $1.04
• Quarter ended Sep 30, 2022: revenue $289M (up 4.7% year over year), net income $51.0M, EPS $1.02
• Quarter ended Jun 30, 2022: revenue $277M (up 2.9% year over year), net income $55.3M, EPS $1.09
• Quarter ended Mar 31, 2022 (from the annual report): revenue $267M, net income $52.1M, EPS $1.02
• Quarter ended Dec 31, 2021: revenue $274M, net income $50.2M, EPS $0.99
• Quarter ended Sep 30, 2021: revenue $276M, net income $45.3M, EPS $0.89

PBH cash flow, buybacks and dividends

• Fiscal year ended Mar 2026: operating cash flow $258M, share buybacks $156M
• Fiscal year ended Mar 2025: operating cash flow $252M, share buybacks $51.5M
• Fiscal year ended Mar 2024: operating cash flow $249M, share buybacks $25.0M
• Fiscal year ended Mar 2023: operating cash flow $230M, share buybacks $50.0M
• Fiscal year ended Mar 2022: operating cash flow $260M, share buybacks $0

PBH balance sheet

• Jun 30, 2026: cash $89.1M, total assets $4.57B, total liabilities $2.65B, shareholders' equity $1.92B, long-term debt $2.01B
• Mar 31, 2026: cash $63.9M, total assets $3.49B, total liabilities $1.61B, shareholders' equity $1.89B, long-term debt $994M
• Dec 31, 2025: cash $62.4M, total assets $3.49B, total liabilities $1.67B, shareholders' equity $1.83B
• Sep 30, 2025: cash $119M, total assets $3.44B, total liabilities $1.62B, shareholders' equity $1.82B
• Jun 30, 2025: cash $140M, total assets $3.43B, total liabilities $1.58B, shareholders' equity $1.86B
• Mar 31, 2025: cash $97.9M, total assets $3.40B, total liabilities $1.57B, shareholders' equity $1.83B
• Dec 31, 2024: cash $50.9M, total assets $3.33B, total liabilities $1.54B, shareholders' equity $1.79B, long-term debt $1.00B
• Sep 30, 2024: cash $51.5M, total assets $3.32B, total liabilities $1.59B, shareholders' equity $1.73B, long-term debt $1.06B

What is PBH's revenue?

PRESTIGE CONSMR HEALTHCARE I reported $1.10B of revenue over its last four quarters, through June 30, 2026.

Is PBH profitable?

Yes. PRESTIGE CONSMR HEALTHCARE I earned $172M over the last four quarters.

What is PBH's EPS?

Diluted earnings per share over the last four quarters were $3.57; $0.61 in the latest quarter.

PBH ownership and insider trades · All stocks